[Treatment of arterial hypertension in pregnancy with an alpha-beta blocker. 58 Cases treated with labetalol].
The results of the treatment in hypertension with pregnancy by a alpha-beta blocker in 58 women show: the good tolerance of the drug and its lack of teratogenic effect, its quasi-constant efficiency (91%) in hypertension, its benefit repercussion on neonatal weight. However, this therapeutics requires a maternal careful watching all along pregnancy, and especially of the new-born children, with regard to the risk of hypoglycemia.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D000328:Adult; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D005315:Fetal Diseases / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007003:Hypoglycemia / Q000209:etiology; D007741:Labetalol / Q000009:adverse effects / Q000627:therapeutic use*; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D007741:Labetalol
Traitement de l'hypertension artérielle gravidique par un alpha-bêtabloquant. 58 cas traités par labétalol.